Two Sigma Advisers
BCAB icon

Two Sigma Advisers’s BioAtla BCAB Stock Holding History

Two Sigma Advisers’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-282
Closed -$5.58K – 2363
2025
Q2 		$5.58K Sell
282
-3,496
-93% -$70.9K ﹤0.01% 2299
2025
Q1 		$65.5K Buy
3,778
+2,548
+207% +$54.5K ﹤0.01% 2294
2024
Q4 		$36.4K Sell
1,230
-611
-33% -$51.3K ﹤0.01% 2304
2024
Q3 		$162K Sell
1,841
-1,225
-40% -$103K ﹤0.01% 2109
2024
Q2 		$210K Sell
3,066
-2,928
-49% -$348K ﹤0.01% 2196
2024
Q1 		$1.03M Buy
5,994
+776
+15% +$96.4K ﹤0.01% 1569
2023
Q4 		$642K Buy
5,218
+84
+2% +$7.28K ﹤0.01% 1822
2023
Q3 		$436K Sell
5,134
-914
-15% -$116K ﹤0.01% 1838
2023
Q2 		$907K Sell
6,048
-996
-14% -$171K ﹤0.01% 1575
2023
Q1 		$944K Buy
7,044
+60
+0.9% +$10.8K ﹤0.01% 1662
2022
Q4 		$2.88M Sell
6,984
-176
-2% -$73K 0.01% 1039
2022
Q3 		$2.76M Sell
7,160
-1,216
-15% -$398K 0.01% 1012
2022
Q2 		$1.19M Buy
8,376
+2,360
+39% +$376K ﹤0.01% 1496
2022
Q1 		$1.5M Buy
6,016
+2,994
+99% +$1.25M ﹤0.01% 1414
2021
Q4 		$2.97M Buy
+3,022
New +$3.87M 0.01% 1003

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers's BCAB Position: Q3 2025 in Review

Two Sigma Advisers sold out of BioAtla (BCAB) in Q3 2025, closing a stake of 282 shares — an estimated $5.58K sold.

Two Sigma Advisers first reported a position in BCAB in Q4 2021 and held it in 15 quarters. The position peaked at $2.97M in Q4 2021. 43 funds tracked by Wall St. Rank hold BCAB as of Q3 2025.

  • Two Sigma Advisers reported no remaining BioAtla position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 282 BioAtla shares in Q3 2025, an estimated $5.58K.
  • Two Sigma Advisers first reported a position in BioAtla in Q4 2021 and held it in 15 quarters.
  • Two Sigma Advisers's BioAtla position peaked at $2.97M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held BioAtla as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.